市场调查报告书
商品编码
1422770
全球光学相干断层扫描市场:按类型、技术、应用、地区、机会、预测,2017-2031 年Optical Coherence Tomography Market Assessment, By Type, By Technology, By Applications, By Region, Opportunities and Forecast, 2017-2031F |
2023年全球光学相干断层扫描市场规模达15.1亿美元。预计到 2031 年,该市场将达到 32.9 亿美元,2024-2031 年预测期间复合年增长率为 10.23%。全球光学相干断层扫描市场受到技术进步、眼部疾病(如青光眼和老年黄斑部病变)发病率增加、对非侵入性诊断方法的需求不断增长的推动,多种因素正在影响这一市场,包括在各种医疗领域。此外,光学相干断层扫描市场的扩张是由不断扩大的研究计划和快速增加的医疗保健支出所推动的。
全球光学相干断层扫描市场受到推动其成长的多种因素的影响。技术进步至关重要,并且正在不断提高 OCT 的准确性、速度和解析度。这提高了诊断能力并促进其在各个医疗领域的使用。青光眼和老年黄斑部病变等眼部相关疾病的增加对市场成长做出了重大贡献。OCT 的非侵入性性质满足了对更安全、更有效的诊断工具日益增长的需求,并促进了其在识别和追踪这些疾病方面的应用。OCT正在从眼科扩展到心臟科和皮肤科等领域,扩大全球光学相干断层扫描市场的潜力。其高品质影像有助于心臟组织和皮肤的分析,为非传统医学领域创造新的机会。
此外,全球光学相干断层扫描市场的成长是由旨在发现新应用和改进现有 OCT 技术的持续研究举措所推动的。同时,全球医疗保健支出的快速成长正在成为扩大医疗机构内 OCT 技术的使用和采用的催化剂。这些因素的结合将扩大全球光学相干断层扫描市场,推动创新,使应用多样化,并改善医疗领域的诊断和治疗监测。
各种眼部疾病,特别是青光眼和老年黄斑部病变等疾病的发生率不断增加,大大推动了光学相干断层扫描市场的崛起。随着这些眼疾在全球范围内不断增加,对先进、非侵入性诊断解决方案的需求日益增长。OCT 的非侵入性和卓越的高解析度影像在这些眼睛相关问题的检测、追踪和管理中发挥着至关重要的作用。OCT 能够提供复杂的、分层的眼部结构影像,从而能够及早发现疾病并准确监测病情进展。对准确有效的诊断技术不断增长的需求完全符合 OCT 的能力,巩固了其作为眼科领域关键仪器的地位,并为市场的向上增长做出了重大贡献。
该报告研究了全球光学相干断层扫描市场,并提供了市场概述,包括按类型、技术、应用、地区和参与市场的公司概况划分的趋势。
Global optical coherence tomography market size was valued at USD 1.51 billion in 2023, which is expected to reach USD 3.29 billion in 2031, with a CAGR of 10.23% for the forecast period between 2024 and 2031F. Various elements impact global optical coherence tomography market, encompassing technological progress, heightened occurrences of eye ailments (such as glaucoma and age-related macular degeneration), a growing need for non-invasive diagnostic methods, and its increasing application in diverse medical fields beyond ophthalmology, like cardiology and dermatology. Furthermore, the expansion of the global optical coherence tomography market is bolstered by expanding research initiatives and an upsurge in healthcare spending.
The global optical coherence tomography market is influenced by various factors that fuel its growth. Technological advancements are pivotal, consistently improving OCT's precision, speed, and resolution. It enhances diagnostic capabilities and encourages its use across various medical fields. Increasing eye-related conditions, such as glaucoma and age-related macular degeneration, significantly contribute to the market's growth. OCT's non-invasive nature meets the rising demand for safer and more effective diagnostic tools, driving its application in identifying and tracking these ailments. OCT's expansion beyond ophthalmology into areas like cardiology and dermatology widens the potential of global optical coherence tomography market. Its high-quality imaging facilitates the analysis of cardiac tissues and skin, creating new opportunities in unconventional medical domains.
Furthermore, the growth of global optical coherence tomography market is propelled by ongoing research initiatives that aim to discover new applications and refine existing OCT technologies. Simultaneously, the surge in global healthcare expenditure acts as a catalyst, enabling wider accessibility and adoption of OCT technologies within healthcare facilities. The combination of elements supports the expansion of global optical coherence tomography market, promoting innovation, diversifying its applications, and improving healthcare diagnostics and treatment monitoring across a spectrum of medical fields.
Increased Occurrences of Eye Ailments
The increasing occurrence of diverse eye conditions, especially ailments like glaucoma and age-related macular degeneration, significantly propels the thriving global optical coherence tomography market. As these ocular disorders continue their global rise, there's a growing need for advanced and non-invasive diagnostic solutions. OCT's non-intrusive features and exceptional high-resolution imaging play a pivotal role in detecting, tracking, and managing these eye-related issues. Its capacity to offer intricate, layered images of the eye's structure enables early identification and precise monitoring of disease advancement. This amplified requirement for precise and effective diagnostic techniques perfectly matches OCT's capabilities, firmly establishing it as a crucial instrument in the ophthalmic domain and substantially contributing to the market's upward growth trajectory.
Increased focus on Research and Innovation
Research and innovation investments are the driving forces behind the expansion of global optical coherence tomography market. Ongoing funding for improving OCT technologies refines its precision, speed, and adaptability across various medical disciplines. The financial support stimulates the creation of state-of-the-art functionalities, enhancing diagnostic capacities and broadening its utilization in medical specialties beyond ophthalmology. These investments encourage exploration into new applications, propelling OCT into uncharted territories within medical imaging. Ultimately, this commitment to advancing research and innovation solidifies OCT's growth, establishing its pivotal role as a crucial diagnostic tool across diverse medical sectors and propelling the market's continual expansion. The Centre for Ophthalmic Artificial Intelligence and Human Health was established in July 2023 by The Icahn School of Medicine at Mount Sinai. It was the first center of its sort in New York and among the first in the country. By developing high-resolution optical coherence tomography, the Centre is committed to improving artificial intelligence (AI) in ophthalmology and solidifying the Mount Sinai Health System's position as a frontrunner in patient care via innovative ideas and technologies.
Government Initiatives
Governments worldwide actively engage in initiatives to strengthen the global optical coherence tomography market. These endeavors involve supporting funding, establishing regulatory frameworks, and fostering collaborations to promote research, innovation, and accessibility. Financial grants and incentives propel technological advancements, refining OCT's precision and expanding its applicability in various medical domains. Regulatory measures ensure adherence to safety standards, instilling trust in its utilization. Partnerships between governments, research entities, and industry stakeholders facilitate the exchange of knowledge, propelling OCT's progress and adoption.
These coordinated efforts demonstrate a collective dedication to fortify OCT's pivotal role in diagnostics, advancing its growth and widespread integration in global healthcare systems. A Tamil Nadu health minister unveiled the Optical Coherence Tomography equipment for cardiac catheterization, valued at INR 1.5 crore, at the Coimbatore Medical College Hospital (CMCH) in November 2023 as part of the Chief Minister's Comprehensive Health Insurance Scheme. Additional facilities were unveiled at the government hospitals in Mettupalayam and Somanur.
Use of OCT in Ophthalmology
The increasing necessity for optical coherence tomography (OCT) within ophthalmology significantly drives the growth of the global optical coherence tomography market. The growing demand arises from OCT's capacity for non-invasive imaging, delivering detailed cross-sectional views of eye structures. Its capabilities enable early identification, precise monitoring, and customized treatment approaches for conditions such as macular degeneration and glaucoma. Ophthalmologists value OCT for its provision of high-resolution, real-time imagery, elevating diagnostic precision and patient care. With OCT's mounting reliance on ophthalmic practices worldwide, its foundational role strengthens, propelling the market expansion and cementing its status as a fundamental technology in eye healthcare. Visionix USA introduced their new multimodal, high-speed Optovue FullRange OCT system to the North American market in February 2023. The Optovue Solix FullRange OCT has integrated cameras for fundus, external photography, and external infrared imaging, in addition to enhanced scans and new posterior high-density scan patterns that provide greater detail and accuracy.
Growing Demand for Catheter-Based OCT Devices
The increasing desire for catheter-based optical coherence tomography (OCT) tools shapes the growth of optical coherence tomography market. These specialized devices enable high-resolution internal imaging within blood vessels and organs, aiding precise real-time visualization during minimally invasive procedures, particularly in cardiology for intravascular imaging. They guide interventions and bolster diagnostic precision. With a shift in medical practices toward less invasive methods, the amplified need for catheter-based OCT devices arises from their capacity to provide intricate, detailed images. The pivotal role in various medical fields accentuates their importance, substantially driving the expansion of global optical coherence tomography market. The Tiger-eye ST next generation image-guided chronic total occlusion (CTO) crossing system was introduced by Avinger Inc. in September 2023. For the diagnosis and treatment of vascular disease, it is the first and only intravascular image-guided catheter device. Using optical coherence tomography as an imaging modality, clinicians may look inside the artery during an atherectomy or CTO-crossing treatment due to Avinger's Lumivascular technology, which includes an onboard image-guidance system.
Outlook of Global Optical Coherence Tomography Market
The global market for optical coherence tomography (OCT) shows promises due to various factors. OCT, an imaging technique without invasiveness, has extensive uses in fields like ophthalmology, cardiology, and dermatology, enabling detailed cross-sectional imaging of tissues. Technological advancements consistently enhance its abilities, boosting the quality, depth, and speed of scans. Rising rates of chronic diseases such as diabetes and cardiovascular conditions fuel the demand for OCT, particularly in early detection and monitoring. Furthermore, the increasing elderly population is more susceptible to age-related illnesses, contributing significantly to market expansion. Ongoing research and development initiatives aim to broaden OCT's applications and reduce costs, facilitating its wider adoption in healthcare facilities. Combining these aspects, the global optical coherence tomography market is on a trajectory for growth, offering innovative solutions for diagnosing, treating, and monitoring various medical conditions across diverse specialties.
Key Players Landscape and Outlook
Major players in the global optical coherence tomography market are proactively engaging in collaborative efforts. These partnerships entail the convergence of industry leaders with research entities, healthcare providers, or technology enterprises. The union allows these significant corporations to combine their knowledge, resources, and technological prowess to propel the progress of OCT. Collaborations serve as catalysts for pioneering applications, refining device accuracy, and venturing into novel medical territories outside ophthalmology. Such strategic partnerships propel technological progress and stimulate market expansion by enriching product portfolios, diversifying applications, and ensuring the continual evolution of OCT technologies across a spectrum of medical fields.
The vendor agreement for eyeMO (Patient Based Ophthalmology Suite), a portable, affordable, home-based, remote, and in-office ophthalmic OCT*1 device for retinal disease monitoring, was executed by Kubota Vision Inc., a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., on December 6, 2023. The compact handheld gadget fills a demand in mobile health applications by enabling patients to self-monitor their retinal health from home or from distant field sites.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work